Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2019 3
2020 2
2021 2
2022 5
2023 5
2024 4
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
[Bronchoscopic COPD treatments].
Egenod T, Deslee G, Degano B. Egenod T, et al. Rev Mal Respir. 2023 Nov-Dec;40(9-10):820-833. doi: 10.1016/j.rmr.2023.08.003. Epub 2023 Sep 6. Rev Mal Respir. 2023. PMID: 37684196 Review. French.
Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial.
Cascone T, Bonanno L, Guisier F, Insa A, Liberman M, Bylicki O, Livi L, Egenod T, Corre R, Kim DW, Garcia Campelo MR, Provencio Pulla M, Shim BY, Metro G, Bennouna J, Bielska AA, Yohannes AR, He Y, Dowson A, Kar G, McGrath L, Kumar R, Grenga I, Spicer J, Forde PM. Cascone T, et al. Among authors: egenod t. Nat Med. 2025 Aug;31(8):2788-2796. doi: 10.1038/s41591-025-03746-z. Epub 2025 May 31. Nat Med. 2025. PMID: 40450142 Free PMC article. Clinical Trial.
[The rise of interventional pulmonology: A special issue coordinated by the GETIF].
Guibert N, Dutau H, Escarguel B, Egenod T, Fournier C, Legodec J, Trosini-Desert V, Lorut C, Lachkar S, Vergnon JM. Guibert N, et al. Among authors: egenod t. Rev Mal Respir. 2022 May;39(5):409-410. doi: 10.1016/j.rmr.2022.04.001. Epub 2022 May 12. Rev Mal Respir. 2022. PMID: 35570032 French. No abstract available.
Recurrent respiratory papillomatosis in adults with lower respiratory tract involvement: a retrospective study of the OrphaLung and GETIF networks.
Ratsihorimanana R, Maitre T, Dusselier M, Triet Ngo M, Mangiapan G, Fournier C, Bourdin A, Jouneau S, Matar M, Favrolt N, Egenod T, Vergnon JM, Wermert D, Boitiaux JF, Borie R, Caliandro R, Freynet O, Gounant V, Mankikian J, Camuset J, Elabbadi A, Parrot A, Calvani J, Fortin M, Guibert N, Cottin V, Cadranel J. Ratsihorimanana R, et al. Among authors: egenod t. Eur Respir J. 2025 Mar 6;65(3):2400618. doi: 10.1183/13993003.00618-2024. Print 2025 Mar. Eur Respir J. 2025. PMID: 39915056 Free article.
Bilateral endobronchial valves treatment for severe emphysema.
Guibert N, Fumat R, Dupuis M, Dusselier M, Favard F, Heluain V, Mallah S, Barthes R, Simonneau Y, Egenod T. Guibert N, et al. Among authors: egenod t. ERJ Open Res. 2022 Apr 11;8(2):00672-2021. doi: 10.1183/23120541.00672-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35415190 Free PMC article.
Role of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction Due to Small Cell Lung Cancer: Results From the EpiGETIF Registry.
Tronchetti J, Roy P, Laroumagne S, Lovato JB, Legodec J, Fournier C, Cellerin L, Lorut C, Gonin F, Vergnon JM, Egenod T, Bourinet V, Camuset J, Degot T, Mangiapan G, Edme J, Astoul P, Guibert N, Dutau H; Francophone Thoracic and Interventional Endoscopy Group, GETIF. Tronchetti J, et al. Among authors: egenod t. Arch Bronconeumol. 2025 Jul;61(7):440-442. doi: 10.1016/j.arbres.2025.03.007. Epub 2025 Mar 20. Arch Bronconeumol. 2025. PMID: 40240278 Free article. English, Spanish. No abstract available.
Pneumatocoeles after bronchoscopic lung volume reduction with valves.
Lestelle F, Fumat R, Didier A, Collot S, Egenod T, Faviez G, Hermant C, Plat G, Guibert N. Lestelle F, et al. Among authors: egenod t. ERJ Open Res. 2021 Apr 6;7(2):00747-2020. doi: 10.1183/23120541.00747-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33834053 Free PMC article.
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study.
Girard N, Galland-Girodet S, Avrillon V, Besse B, Duruisseaux M, Cadranel J, Otto J, Prevost A, Roch B, Bennouna J, Bouledrak K, Coudurier M, Egenod T, Lamy R, Ricordel C, Moro-Sibilot D, Odier L, Tillon-Strozyk J, Zalcman G, Missy P, Westeel V, Baldacci S. Girard N, et al. Among authors: egenod t. ESMO Open. 2022 Apr;7(2):100418. doi: 10.1016/j.esmoop.2022.100418. Epub 2022 Feb 26. ESMO Open. 2022. PMID: 35227966 Free PMC article.
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
Wislez M, Mazieres J, Lavole A, Zalcman G, Carre O, Egenod T, Caliandro R, Dubos-Arvis C, Jeannin G, Molinier O, Massiani MA, Langlais A, Morin F, Le Pimpec Barthes F, Brouchet L, Assouad J, Milleron B, Damotte D, Antoine M, Westeel V. Wislez M, et al. Among authors: egenod t. J Immunother Cancer. 2022 Oct;10(10):e005636. doi: 10.1136/jitc-2022-005636. J Immunother Cancer. 2022. PMID: 36270733 Free PMC article.
28 results